Kerala's Mumps Surge Reignites Calls for MMR Vaccine in Universal Programme

Health authorities and medical experts in Kerala are intensifying calls for the inclusion of the measles-mumps-rubella (MMR) vaccine in the national Universal Immunisation Programme, citing evidence from the state's prolonged mumps outbreak.

Recent epidemiological studies conducted in Kerala have revealed troubling immunity gaps across the child population, raising concerns about vulnerability to mumps and related complications. Researchers have documented cases where mumps infection has led to severe outcomes capable of causing long-term disability, underscoring the public health significance of the outbreak.

A key finding from investigations into the outbreak concerns genetic variations between the mumps virus strains currently circulating in Kerala and the strain incorporated into existing MMR vaccines. These variations may partly explain the persistence of cases despite existing vaccination efforts, prompting experts to reassess immunisation strategies.

The MMR vaccine currently remains absent from India's Universal Immunisation Programme, a gap that public health advocates argue significantly hampers disease prevention efforts. The renewed momentum for its inclusion comes as the state grapples with the health and economic burden of the ongoing outbreak, with medical professionals emphasizing the vaccine's potential to prevent future transmission.